Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma
A new study in Advanced Science (October 12, 2026) shows what becomes possible when patients donate tumor tissue and researchers…
Two Leaders, One Mission: Nathan Imperiale and Philip Leider on Synovial Sarcoma
Our Chairman of the Board of Directors, Nathan Imperiale, was recently invited by Philip Leider, President of the Board of…
Synovial Sarcoma of the Hyoid Bone: A Rare Case
A case report by Ryan Toledo, Jennifer Khong, and colleagues (published August 31, 2026; DOI: 10.7812/TPP/26.039) describes only the third…
Two New TCR-NK Cell Therapy Trials Now Recruiting for Synovial Sarcoma
Two clinical trials testing TCR-NK cell therapy for advanced synovial sarcoma are now recruiting patients, one in the United States…
The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma
A new study published in PLOS One by Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim from Seoul National University and…
Synovial Sarcoma Foundation Launches Ambassador Program During Childhood Cancer Awareness Month
New program invites patients, survivors, caregivers, and families to turn lived experience into advocacy. [Philadelphia, PA], September 1, 2026: This…
How Better T Cell Manufacturing Could Unlock the Next Wave of Synovial Sarcoma Therapies
A study published in Cytotherapy by Kayo Toishigawa, Kenta Magoori, Hiroyuki Sato, and colleagues at Hiroshima University, in collaboration with…
Why a Melanoma Vaccine Breakthrough Matters for Synovial Sarcoma
Merck and Moderna are making headlines after their personalized mRNA cancer vaccine entered Phase 3 clinical trials for melanoma. For…
A New CAR-T Cell Approach for Synovial Sarcoma That Does Not Require HLA Matching
A new preclinical study published in Biomedicine and Pharmacotherapy by Tomohiro Miyazaki, Yudai Murayama, Naoki Oike, and colleagues from the…